These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 16847422)
1. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422 [TBL] [Abstract][Full Text] [Related]
2. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium. Gibson TM; Smedby KE; Skibola CF; Hein DW; Slager SL; de Sanjosé S; Vajdic CM; Zhang Y; Chiu BC; Wang SS; Hjalgrim H; Nieters A; Bracci PM; Kricker A; Zheng T; Kolar C; Cerhan JR; Darabi H; Becker N; Conde L; Holford TR; Weisenburger DD; De Roos AJ; Butterbach K; Riby J; Cozen W; Benavente Y; Palmers C; Holly EA; Sampson JN; Rothman N; Armstrong BK; Morton LM Cancer Causes Control; 2013 Jan; 24(1):125-34. PubMed ID: 23160945 [TBL] [Abstract][Full Text] [Related]
3. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma. Kilfoy BA; Zheng T; Lan Q; Han X; Holford T; Hein DW; Qin Q; Leaderer B; Morton LM; Yeager M; Boyle P; Zhao P; Chanock S; Rothman N; Zhang Y Cancer Causes Control; 2010 Jan; 21(1):127-33. PubMed ID: 19809881 [TBL] [Abstract][Full Text] [Related]
4. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594 [TBL] [Abstract][Full Text] [Related]
5. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Morton LM; Bernstein L; Wang SS; Hein DW; Rothman N; Colt JS; Davis S; Cerhan JR; Severson RK; Welch R; Hartge P; Zahm SH Carcinogenesis; 2007 Aug; 28(8):1759-64. PubMed ID: 17522066 [TBL] [Abstract][Full Text] [Related]
6. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Gu J; Liang D; Wang Y; Lu C; Wu X Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609 [TBL] [Abstract][Full Text] [Related]
7. N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes. Cocco P; Zucca M; Sanna S; Satta G; Nonne T; Angelucci E; Gabbas A; Rais M; Malpeli G; Campagna M; Scarpa A; G Ennas M Hematol Oncol; 2016 Jun; 34(2):79-83. PubMed ID: 25689677 [TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma. Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843 [TBL] [Abstract][Full Text] [Related]
9. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study. Matejcic M; Vogelsang M; Wang Y; Iqbal Parker M BMC Cancer; 2015 Mar; 15():150. PubMed ID: 25886288 [TBL] [Abstract][Full Text] [Related]
10. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
11. Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study. Nöthlings U; Yamamoto JF; Wilkens LR; Murphy SP; Park SY; Henderson BE; Kolonel LN; Le Marchand L Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2098-106. PubMed ID: 19549810 [TBL] [Abstract][Full Text] [Related]
12. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Hein DW Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146 [TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk. Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715 [TBL] [Abstract][Full Text] [Related]
14. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961 [TBL] [Abstract][Full Text] [Related]
15. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Suzuki H; Morris JS; Li Y; Doll MA; Hein DW; Liu J; Jiao L; Hassan MM; Day RS; Bondy ML; Abbruzzese JL; Li D Carcinogenesis; 2008 Jun; 29(6):1184-91. PubMed ID: 18499698 [TBL] [Abstract][Full Text] [Related]
16. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population. Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937 [TBL] [Abstract][Full Text] [Related]
17. Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Butler LM; Millikan RC; Sinha R; Keku TO; Winkel S; Harlan B; Eaton A; Gammon MD; Sandler RS Mutat Res; 2008 Feb; 638(1-2):162-74. PubMed ID: 18022202 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Ishibe N; Sinha R; Hein DW; Kulldorff M; Strickland P; Fretland AJ; Chow WH; Kadlubar FF; Lang NP; Rothman N Pharmacogenetics; 2002 Mar; 12(2):145-50. PubMed ID: 11875368 [TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782 [TBL] [Abstract][Full Text] [Related]
20. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]